<?xml version="1.0" encoding="UTF-8"?>
<p>As an example, in the past year CEPI launched requests for proposals and signed several partnership agreements for the distribution of Lassa virus-specific antigens and the development of aÂ Lassa antibody standard. In collaboration with the Viral Hemorrhagic Fever Consortium (VHFC), the Bernhard Nocht Institute for Tropical Medicine (BNITM), and the National Institute of Biological Standards and Control (NIBSC), CEPI is collecting serum from individuals who recovered from the disease in endemic countries (Sierra Leone, Liberia, Mali, and Nigeria) for the development of reference antibody preparation and, ultimately, an IRP available to all globally.</p>
